Here, we used a highly specific antibody that is predicted to detect all glycoforms and splice variants of human CEACAM1 to provide a comprehensive assessment of human CEACAM1 expression on tumor-infiltrating immune cells through an analysis of melanoma. This evidence concerns the gene CEACAM1 and neoplasm.